/5
0 avis
Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.
Archive ouverte
Edité par CCSD ; Public Library of Science -
International audience
Consulter en ligne
Chargement des enrichissements...